Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Turk J Gastroenterol ; 28(Suppl 2): 90-93, 2017 12.
Article in English | MEDLINE | ID: mdl-29303105

ABSTRACT

The present guideline updates the Turkish recommendations for the screening, diagnosis and management of Hepatitis C virus (HCV) infection prepared by the Turkish Association for the Study of the Liver (TASL) and Viral Hepatitis Society (VHS). The aim of this guidance was to provide updates recommendations to physicians, who are interested in HCV care on the optimal screening, diagnosis and pre-treatment management for patients with HCV infection in Turkey. These recommendations, produced by panel experts, were aimed to addresses the management issues ranging from diagnosis and linkage to care, to the optimal treatment regimen in patients with HCV infection. Recommendations are based on evidence and opinions of more than 70% of the panelists. This guidance is supported by the memberships of two societies and not by pharmaceutical companies. This guidance will be updated frequently as new data become available.


Subject(s)
Disease Management , Hepatitis C , Antiviral Agents/standards , Antiviral Agents/therapeutic use , Hepacivirus , Humans , Liver Cirrhosis/virology , Liver Function Tests/standards , Turkey
2.
Dig Dis Sci ; 50(6): 1141-5, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15986871

ABSTRACT

The aim of this study was to investigate if there was any relationship between nonalcoholic steatohepatitis and the rate of Chlamydia pneumoniae seropositivity in a male population. Fifteen men with nonalcoholic steatohepatitis and 20 healthy men were enrolled in the study. The seropositivity rate of Chlamydia pneumoniae immunoglobulin A in the nonalcoholic steatohepatitis and control groups was 53.3 and 5%, respectively. The rate of Chlamydia pneumoniae immunoglobulin A positivity was significantly higher in the nonalcoholic steatohepatitis group than the controls (P = 0.002), while such a difference did not occur for Chlamydia pneumoniae immunoglobulin G positivity (P > 0.05). There is an association between nonalcoholic steatohepatitis and persistent Chlamydia pneumoniae infection as a probable causative or triggering agent. These findings suggest that further studies are necessary to clarify this association.


Subject(s)
Chlamydia Infections/immunology , Chlamydophila pneumoniae/immunology , Fatty Liver/microbiology , Adult , Chlamydia Infections/complications , Chlamydia Infections/epidemiology , Fatty Liver/immunology , Humans , Immunoglobulin A/immunology , Male , Middle Aged , Seroepidemiologic Studies , Sex Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...